We are live on ! Find out more
RBC

Ronald Blue & Co Portfolio holdings

AUM $3.1B
1-Year Est. Return 12.82%
This Fund
S&P 500
This Quarter Est. Return
-4.34%
1 Year Est. Return
+12.82%
3 Year Est. Return
+2.44%
5 Year Est. Return
10 Year Est. Return
AUM
$1.54B
AUM Growth
-$34.5M
Cap. Flow
+$38M
Cap. Flow %
2.47%
Top 10 Hldgs %
83.76%
Holding
365
New
24
Increased
151
Reduced
141
Closed
30

Sector Composition

Rank Sector Weight
1 Healthcare 2.76%
2 Financials 2.58%
3 Energy 1.96%
4 Industrials 1.89%
5 Consumer Staples 1.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZN icon
101
AstraZeneca
AZN
$263B
$789K 0.05%
11,046
+2,161
+24% +$158K
META icon
102
Meta Platforms (Facebook)
META
$1.42T
$781K 0.05%
9,874
-1,039
-10% -$76.2K
AXP icon
103
American Express
AXP
$227B
$769K 0.05%
8,788
+1,119
+15% +$101K
NSC icon
104
Norfolk Southern
NSC
$75.4B
$769K 0.05%
6,883
-811
-11% -$86K
ABT icon
105
Abbott
ABT
$183B
$768K 0.05%
18,455
-215
-1% -$9.1K
BKNG icon
106
Booking.com
BKNG
$149B
$767K 0.05%
16,550
+750
+5% +$36.9K
BIIB icon
107
Biogen
BIIB
$30B
$763K 0.05%
2,308
+241
+12% +$79.5K
TFCFA
108
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$762K 0.05%
22,233
-3,395
-13% -$117K
UN
109
DELISTED
Unilever NV New York Registry Shares
UN
$760K 0.05%
19,144
+1,127
+6% +$47K
ARMH
110
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$758K 0.05%
17,343
+1,739
+11% +$78.9K
CMCSA icon
111
Comcast
CMCSA
$85B
$752K 0.05%
27,992
+4,670
+20% +$128K
GLD icon
112
SPDR Gold Trust
GLD
$131B
$745K 0.05%
6,411
+879
+16% +$108K
KMB icon
113
Kimberly-Clark
KMB
$36.3B
$745K 0.05%
7,229
-203
-3% -$21.1K
BMY icon
114
Bristol-Myers Squibb
BMY
$133B
$739K 0.05%
14,421
-709
-5% -$35.4K
IDV icon
115
iShares International Select Dividend ETF
IDV
$8.45B
$721K 0.05%
20,144
-2,350
-10% -$90.3K
LMT icon
116
Lockheed Martin
LMT
$134B
$716K 0.05%
3,917
-813
-17% -$138K
BHP icon
117
BHP
BHP
$215B
$696K 0.05%
13,986
+1,644
+13% +$95.6K
NVO
118
Novo Nordisk
NVO
$208B
$693K 0.05%
29,132
+412
+1% +$9.48K
BCE icon
119
BCE
BCE
$20.2B
$677K 0.04%
15,840
+760
+5% +$34K
CEO
120
DELISTED
CNOOC Limited
CEO
$661K 0.04%
3,833
+1,885
+97% +$348K
MCK icon
121
McKesson
MCK
$100B
$660K 0.04%
3,388
+170
+5% +$32.7K
RDS.B
122
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$659K 0.04%
8,320
+336
+4% +$28.3K
CVS icon
123
CVS Health
CVS
$133B
$657K 0.04%
8,248
-882
-10% -$69.5K
HDB icon
124
HDFC Bank
HDB
$123B
$654K 0.04%
56,176
+788
+1% +$9.55K
MON
125
DELISTED
Monsanto Co
MON
$642K 0.04%
5,712
-1,185
-17% -$139K

Similar funds

Ronald Blue & Co's Q3 2014 Portfolio in Review

As of Q3 2014, Ronald Blue & Co held 365 positions worth $1.54B, down 2.2% from $1.57B the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Ronald Blue & Co's Q3 2014 filing shows 24 new, 151 increased, 141 reduced and 30 closed positions. Its largest new stake was Prosperity Bancshares: 55,482 shares worth $3.17M. The largest sale was iShares MSCI ACWI ETF, an estimated $2.64M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.5% a quarter earlier, followed by Financials and Energy.

  • Ronald Blue & Co's largest Q3 2014 buy was Prosperity Bancshares: 55,482 shares worth $3.17M.
  • Ronald Blue & Co added most to Vident International Equity Strategy in Q3 2014, an estimated $21M increase.
  • Ronald Blue & Co's biggest Q3 2014 reduction was iShares MSCI ACWI ETF, cutting an estimated $2.64M.
  • Ronald Blue & Co fully exited SIEMENS AKTIENGESELLSCHAFT ADS in Q3 2014, selling an estimated $789K.
  • Ronald Blue & Co's ten largest holdings make up 84% of its $1.54B portfolio in Q3 2014.
  • Ronald Blue & Co opened 24 new positions and closed 30 in Q3 2014.
  • Ronald Blue & Co's portfolio value fell 2.2% quarter-over-quarter to $1.54B.

Based on Ronald Blue & Co's 13F filing for Q3 2014, filed 14 Nov 2014.